The search for effective treatments often leads through disappointment before finding something that works
Developed by Eli Lilly and currently in Phase 3 clinical trials, it functions as a triple agonist, simultaneously activating three distinct receptor types that regulate appetite, metabolism, and energy expenditure
While these medications can help with weight loss, stopping them often leads to weight regain which in turn increases the likelihood of restarting therapy
If you suspect deficiencies, consult a healthcare provider for testing and personalised recommendations
JavaScript is disabled in your browser
Similarly, -synuclein oligomers intervene with organellar functions and interact with metal ions to cause oxidative stress 14